SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-23-000127
Filing Date
2023-11-08
Accepted
2023-11-08 17:18:23
Documents
14
Period of Report
2023-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20231107x8k.htm   iXBRL 8-K 74402
2 EX-99.1 alim-20231107xex99_1.htm EX-99.1 31958
3 GRAPHIC alim-20231107xex99_1g001.jpg GRAPHIC 55720
  Complete submission text file 0001267602-23-000127.txt   312784

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20231107.xsd EX-101.SCH 2167
5 EX-101.LAB alim-20231107_lab.xml EX-101.LAB 18361
6 EX-101.PRE alim-20231107_pre.xml EX-101.PRE 11525
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20231107x8k_htm.xml XML 4813
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 231389276
SIC: 2834 Pharmaceutical Preparations